SCHEMBL31609104

SCHEMBL31609104

CCCS(=O)(=O)C[C@H]1CCN(C(=O)OC(C)(C)C)C1

nearest known ligand 0.46

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ GPR119 Q8TDV5 8/20 0.43
▸ NR1H2 P55055 1/20 0.42
▸ KDM4E B2RXH2 1/20 0.41
▸ PKM P14618 1/20 0.41
▸ HPGD P15428 1/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ ALDH1A1 P00352 1/20 0.41
▸ MAPT P10636 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ KAT8 Q9H7Z6 2/20 0.40
▸ STS P08842 2/20 0.40
▸ KAT6A Q92794 1/20 0.40
▸ KAT5 Q92993 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30758090 0.91 GPR119 (0.46) GPR119NR1H2KDM4EPKMHPGD
SCHEMBL12136991 0.86 NR1H2 (0.50) GPR119NR1H2KDM4EPKMHPGD
SCHEMBL8426435 0.86 NR1H2 (0.50) GPR119NR1H2KDM4EPKMHPGD
SCHEMBL14514518 0.86 NR1H2 (0.50) GPR119NR1H2KDM4EPKMHPGD
SCHEMBL1318622 0.83 GPR119 (0.46) GPR119NR1H2KDM4EPKMHPGD
SCHEMBL31609153 0.83 GPR119 (0.49) GPR119NR1H2KDM4EPKMHPGD
SCHEMBL1318620 0.83 GPR119 (0.46) GPR119NR1H2KDM4EPKMHPGD
SCHEMBL20690682 0.83 GPR119 (0.49) GPR119NR1H2KDM4EPKMHPGD
SCHEMBL31609166 0.83 GPR119 (0.49) GPR119NR1H2KDM4EPKMHPGD
SCHEMBL20754454 0.82 GPR119 (0.46) GPR119NR1H2KDM4EPKMHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4563579-A1 MACROCYCLIC EGFR INHIBITOR, AND PREPARATION METHOD THEREFOR AND PHARMACEUTICAL USE THEREOF Abbisko Therapeutics Co., Ltd. (CN) 2025-06-04 — — EP disclosed
Send feedback